JOHNSON & JOHNSON

Q3 2025 13F Holdings

  • Location
    new brunswick, NJ
  • Num holdings

    20

  • Value ($000)

    $503,700

  • Date Filed
    11/13/2025
  • Form type
    13F-HR
  • CIK
    0000200406
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
P
PTGX

Protagonist Therapeutics Inc.

COM
74366E102
$162.70M
32 %

2,449,183

N
NBTX

Nanobiotix S.A.

SPONSORED ADS
63009J107
$106.23M
21 %

5,623,816

---

MeiraGTx Holdings plc

COM
G59665102
$54.66M
11 %

6,641,064

R
RAPP

Rapport Therapeutics, Inc.

COM
75383L102
$53.00M
11 %

1,784,517

C
CVRX

CVRx, Inc.

COM
126638105
$33.11M
7 %

4,103,430

L
LEGN

Legend Biotech Corporation

SPONSORED ADS
52490G102
$26.56M
5 %

814,586

C
CTNM

Contineum Therapeutics Inc.

CL A
21217B100
$23.26M
5 %

1,979,173

P
PRCT

Procept BioRobotics Corporation

COM
74276L105
$12.77M
3 %

357,939

X
XNCR

Xencor, Inc.

COM
98401F105
$8.77M
2 %

748,062

A
ARWR

Arrowhead Pharmaceuticals, Inc.

COM
04280A100
$8.54M
2 %

247,598

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 20